A Study of Mitoxantrone Hydrochloride Liposome Injection Combination Therapy in Chinese Patients With Advanced Solid Tumors
Clinical trial NCT05344742 · UNKNOWN
Trial details
- NCT number
- NCT05344742
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-01
- Primary completion
- 2024-03-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.